News
Bharat Biotech Has Submitted Data from Clinical Trials in the 2-18 Years Age Group for ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'Bharat Biotech has submitted data from clinical trials in the 2-18 years age group for COVAXIN to CDSCO. The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee and has provided their positive recommendations.'
Bharat Biotech has submitted data from clinical trials in the 2-18 years age group for COVAXIN (BBV152) to CDSCO. The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee (SEC) and has provided their positive recommendations. pic.twitter.com/NGySZlmNXD— ANI (@ANI) October 12, 2021
(The above story first appeared on LatestLY on Oct 12, 2021 03:14 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
